Suppr
超能文献

Beyond ipilimumab: new approaches target the immunological synapse.

作者信息

Garber Ken

出版信息

J Natl Cancer Inst. 2011 Jul 20;103(14):1079-82. doi: 10.1093/jnci/djr281. Epub 2011 Jul 7.

DOI:10.1093/jnci/djr281

PMID:21737695

Abstract

摘要

相似文献

Beyond ipilimumab: new approaches target the immunological synapse.

J Natl Cancer Inst. 2011 Jul 20;103(14):1079-82. doi: 10.1093/jnci/djr281. Epub 2011 Jul 7.

[New hope in metastatic melanoma treatment?].

Ann Dermatol Venereol. 2012 Oct;139(10):693-4. doi: 10.1016/j.annder.2012.05.030. Epub 2012 Sep 8.

Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.

Nat Rev Drug Discov. 2010 Aug;9(8):584. doi: 10.1038/nrd3245.

New approaches tackle rising pancreatic cancer rates.

J Natl Cancer Inst. 2014 Dec 22;106(12). doi: 10.1093/jnci/dju417. Print 2014 Dec.

Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

Pharmacol Res. 2012 Jan;65(1):9-22. doi: 10.1016/j.phrs.2011.09.002. Epub 2011 Sep 10.

Programmed death protein 1 inhibitors making inroads in multiple cancers.

J Natl Cancer Inst. 2015 May 9;107(5). doi: 10.1093/jnci/djv141. Print 2015 May.

Cocktails for cancer with a measure of immunotherapy.

Nature. 2016 Apr 14;532(7598):162-4. doi: 10.1038/532162a.

Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies.

Tumori. 2013 Nov-Dec;99(6):302e-5e. doi: 10.1700/1390.15474.

Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.

Expert Rev Anticancer Ther. 2015;15(9):981-93. doi: 10.1586/14737140.2015.1074862. Epub 2015 Jul 30.

Melanoma vaccines: possible progress after years of frustration?

J Natl Cancer Inst. 2009 Feb 4;101(3):140-1. doi: 10.1093/jnci/djn508. Epub 2009 Jan 27.

引用本文的文献

Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy.

Int J Mol Sci. 2024 Sep 27;25(19):10454. doi: 10.3390/ijms251910454.

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Nat Rev Clin Oncol. 2016 May;13(5):273-90. doi: 10.1038/nrclinonc.2016.25. Epub 2016 Mar 15.

Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade.

BMC Res Notes. 2016 Feb 13;9:92. doi: 10.1186/s13104-016-1914-9.

Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape.

Cancer Manag Res. 2014 Jun 20;6:279-89. doi: 10.2147/CMAR.S64979. eCollection 2014.

Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells.

J Immunother Cancer. 2013 Sep 23;1:17. doi: 10.1186/2051-1426-1-17. eCollection 2013.

Immune-suppressive properties of the tumor microenvironment.

Cancer Immunol Immunother. 2013 Jul;62(7):1137-48. doi: 10.1007/s00262-013-1434-6. Epub 2013 May 11.

Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7.

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Expert Rev Anticancer Ther. 2012 Dec;12(12):1597-611. doi: 10.1586/era.12.147.

What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?

Immunotherapy. 2012 Aug;4(8):749-51. doi: 10.2217/imt.12.65.

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Biomaterials. 2012 Aug;33(23):5776-87. doi: 10.1016/j.biomaterials.2012.04.029. Epub 2012 May 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Beyond ipilimumab: new approaches target the immunological synapse.

J Natl Cancer Inst. 2011 Jul 20;103(14):1079-82. doi: 10.1093/jnci/djr281. Epub 2011 Jul 7.

[New hope in metastatic melanoma treatment?].

Ann Dermatol Venereol. 2012 Oct;139(10):693-4. doi: 10.1016/j.annder.2012.05.030. Epub 2012 Sep 8.

Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy.

Nat Rev Drug Discov. 2010 Aug;9(8):584. doi: 10.1038/nrd3245.

New approaches tackle rising pancreatic cancer rates.

J Natl Cancer Inst. 2014 Dec 22;106(12). doi: 10.1093/jnci/dju417. Print 2014 Dec.

Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

Pharmacol Res. 2012 Jan;65(1):9-22. doi: 10.1016/j.phrs.2011.09.002. Epub 2011 Sep 10.

Programmed death protein 1 inhibitors making inroads in multiple cancers.

J Natl Cancer Inst. 2015 May 9;107(5). doi: 10.1093/jnci/djv141. Print 2015 May.

Cocktails for cancer with a measure of immunotherapy.

Nature. 2016 Apr 14;532(7598):162-4. doi: 10.1038/532162a.

Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies.

Tumori. 2013 Nov-Dec;99(6):302e-5e. doi: 10.1700/1390.15474.

Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.

Expert Rev Anticancer Ther. 2015;15(9):981-93. doi: 10.1586/14737140.2015.1074862. Epub 2015 Jul 30.

Melanoma vaccines: possible progress after years of frustration?

J Natl Cancer Inst. 2009 Feb 4;101(3):140-1. doi: 10.1093/jnci/djn508. Epub 2009 Jan 27.

引用本文的文献

Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy.

Int J Mol Sci. 2024 Sep 27;25(19):10454. doi: 10.3390/ijms251910454.

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Nat Rev Clin Oncol. 2016 May;13(5):273-90. doi: 10.1038/nrclinonc.2016.25. Epub 2016 Mar 15.

Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade.

BMC Res Notes. 2016 Feb 13;9:92. doi: 10.1186/s13104-016-1914-9.

Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape.

Cancer Manag Res. 2014 Jun 20;6:279-89. doi: 10.2147/CMAR.S64979. eCollection 2014.

Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells.

J Immunother Cancer. 2013 Sep 23;1:17. doi: 10.1186/2051-1426-1-17. eCollection 2013.

Immune-suppressive properties of the tumor microenvironment.

Cancer Immunol Immunother. 2013 Jul;62(7):1137-48. doi: 10.1007/s00262-013-1434-6. Epub 2013 May 11.

Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7.

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Expert Rev Anticancer Ther. 2012 Dec;12(12):1597-611. doi: 10.1586/era.12.147.

What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?

Immunotherapy. 2012 Aug;4(8):749-51. doi: 10.2217/imt.12.65.

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Biomaterials. 2012 Aug;33(23):5776-87. doi: 10.1016/j.biomaterials.2012.04.029. Epub 2012 May 15.

Suppr超能文献

Beyond ipilimumab: new approaches target the immunological synapse.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译